We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZNGA
1251
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$168K 0.01%
44,285
-400
-0.9% -$1.55K
MYF
1252
DELISTED
Blackrock Muni Yield Investment Fund, Inc.
MYF
$166K 0.01%
12,100
+1,100
+10% +$14.8K
NQM
1253
DELISTED
NUVEEN INVESTMENT QLTY MUNI FD
NQM
$164K 0.01%
+12,115
New +$162K
SBY
1254
DELISTED
Silver Bay Realty Trust Corp.
SBY
$163K 0.01%
10,180
-67
-0.7% -$1.06K
AOD
1255
abrdn Total Dynamic Dividend Fund
AOD
$1.13B
$154K ﹤0.01%
18,350
-1,500
-8% -$12.3K
KOS icon
1256
Kosmos Energy
KOS
$1.52B
$151K ﹤0.01%
13,500
-4,000
-23% -$42.8K
PHK
1257
PIMCO High Income Fund
PHK
$878M
$151K ﹤0.01%
13,008
-992
-7% -$11.8K
KEF
1258
DELISTED
Korea Equity Fund
KEF
$151K ﹤0.01%
18,172
-2,912
-14% -$26.3K
MCN
1259
Madison Covered Call & Equity Strategy Fund
MCN
$119M
$150K ﹤0.01%
18,300
MWA icon
1260
Mueller Water Products
MWA
$4.1B
$150K ﹤0.01%
16,000
+3,000
+23% +$25.6K
BSMX
1261
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$150K ﹤0.01%
10,981
-18
-0.2% -$248
ACTG icon
1262
Acacia Research
ACTG
$468M
$149K ﹤0.01%
10,250
-76,666
-88% -$1.21M
AG icon
1263
First Majestic Silver
AG
$9.28B
$145K ﹤0.01%
+14,765
New +$154K
NMY
1264
DELISTED
Nuveen Maryland Quality Municipal Income Fund
NMY
$144K ﹤0.01%
+12,065
New +$144K
SQNM
1265
DELISTED
SEQUENOM INC NEW
SQNM
$142K ﹤0.01%
60,882
-18,692
-23% -$44.3K
NPBC
1266
DELISTED
NATL PENN BANCSHARES INC
NPBC
$141K ﹤0.01%
12,432
WIN
1267
DELISTED
Windstream Holdings Inc
WIN
$140K ﹤0.01%
2,243
-29
-1% -$1.88K
SNOA icon
1268
Sonoma Pharmaceuticals
SNOA
$6.17M
$139K ﹤0.01%
+44
New +$117K
CLNE icon
1269
Clean Energy Fuels
CLNE
$346M
$138K ﹤0.01%
10,713
-3,193
-23% -$39K
TWO
1270
Two Harbors Investment
TWO
$1.27B
$137K ﹤0.01%
+1,858
New +$139K
FCEL icon
1271
FuelCell Energy
FCEL
$1.62B
$136K ﹤0.01%
22
-4
-15% -$24.2K
EDD
1272
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$384M
$135K ﹤0.01%
+10,358
New +$143K
OXSQ icon
1273
Oxford Square Capital
OXSQ
$153M
$135K ﹤0.01%
13,060
-1,852
-12% -$18.9K
BNSO
1274
DELISTED
Bonso Electronic International
BNSO
$135K ﹤0.01%
86,000
AACG
1275
ATA Creativity
AACG
$36.9M
$134K ﹤0.01%
33,328

Similar funds

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.